242947 ⎘
Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof Antigenic peptides or proteins
METHOD OF DETECTING AUTO-ANTIBODIES FROM PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS, A PEPTIDE AND ASSAY KIT
#2Cyclosporine analogue mixtures and their use as immunomodulating agents
#3Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and assay kit
#4Cyclosporine analogue mixtures and their use as immunomodulating agents
#5IgE CH3 peptide vaccine
#6antigens and compositions
#7Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
#8Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
#9HBV CORE ANTIGEN PARTICLES WITH MULTIPLE IMMUNOGENIC COMPONENTS ATTACHED VIA PEPTIDE LIGANDS
#10Deuterated Cyclosporine Analogs and Methods of Making the Same
#11antigens and compositions
#12NEISSERIA MENINGITIDIS ANTIGENS AND COMPOSITIONS
#13antigens and compositions
#14antigens and compositions
#15Porin B (PorB) as a therapeutic target for prevention and treatment of infection by
#16POLYPEPTIDE CARRIER PROTEIN
#17IgE CH3 peptide vaccine
#18Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
#19DEUTERATED CYCLOSPORINE ANALOGS AND METHODS OF MAKING THE SAME
#20Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses
#21Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
#22Contraceptives Based on SP22 and SP22 Antibodies
#23CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS
#24Peptide sequences and compositions
#25Use of flagellin in the immunotherapy of
#26Porin B (PorB) as a therapeutic target for prevention and treatment of infection by
#27COMPOSITIONS AND METHODS FOR WT1 SPECIFIC IMMUNOTHERAPY
#28Peptides with the marburg I polymorphism of factor VII-activating protease (FSAP) and their preparation and uses
#29IMMUNE REACTIVITY TO HER-2/NEU PROTEIN FOR DIAGNOSIS AND TREATMENT OF MALIGNANCIES IN WHICH THE HER-2/NEU ONCOGENE IS ASSOCIATED
#30Synthesis of Cyclosporin Analogs
#31Deuterated Cyclosporine Analogs and Methods of Making the Same
#32Compositions and methods for WT1 specific immunotherapy
#33antigens and compositions
#34Polypeptide carrier protein
#35Recombinant chemokine-antigen vaccine
#36Multiple antigenic peptides immunogenic against
#37Composition comprising a cell expressing an AC133 cell surface antigen and an antibody or antigen-binding fragment
#38Bacteriophage-mediated immunisation against hepatitis
#39Hepatitis-C virus type 4, 5 and 6
#40METHODS AND MATERIALS FOR TREATING INFLAMMATORY CONDITIONS
#41ARL-1 specific antibodies
#42Compositions and methods for WT1 specific immunotherapy
#43Use of Flagellin in Tumor Immunotherapy
#44Porin B (PorB) as a therapeutic target for prevention and treatment of infection by
#45Contraceptives based on SP22 and SP22 antibodies
#46HDV nucleic acid molecules, fragments and applications thereof
#47Cyclosporine Analogue Mixtures and their Use as Immunomodulating Agents
#48Non-anaphylactic forms of grass pollen Ph1 p 6 allergen and their use
#49Contraceptives based on SP22 and SP22 antibodies
#50Use of flagellin in the immunotherapy of
#51Method for isolating and purifying grass pollen allergens
#52Method for isolating and purifying grass pollen allergens
#53Immune reactivity to HER-2/protein for diagnosis and treatment of malignancies in which the HER-2/oncogene is associated
#54Peptide mimics of conserved gonococcal epitopes and methods and compositions using them
#55Peptide mimotopes of mycobacterial mannosylated lipoglycans and uses thereof
#56HBV core antigen particles with multiple immunogenic components attached via peptide ligands
#57Methods of treating or preventing an infectious disease using an immunogenic conjugate of a gram-negative bacterial autoinducer molecule
#58Hepatitis-C virus type 4, 5 and 6
#59Efficient protein expression system
#60Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
#61Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
#62chimeric outer membrane protein PlpE and leukotoxin epitopes as a vaccine or vaccine component against shipping fever
#63Methods of detection of MATER protein autoantibodies
#64Synthesis of cyclosporin analogs
#65Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
#66Conjugate vaccines for the prevention of dental caries
#67Antigen of hybrid M protein and carrier for group a streptococcal vaccine
#68MATER-protein specific antibodies and methods of use
#69Conserved motif of hepatitis C virus E2/NS1 region
#70Polyepitope carrier protein
#71Novel hepatitis B virus
#72Porin B (PorB) as a therapeutic target for prevention and treatment of infection by
#73Vaccine against Gram-negative bacterial infections
#74Deuterated cyclosporine analogs and methods of making the same
#75Methods of making deuterated cyclosporin analogs
#76Antigenic fragments of human factor VIII polypeptides
#77Antibodies which are directed against the Marburg I polymorphism of factor VII-activating protease (FSAP), and their preparation and use
#78epitopes and methods of use thereof
#79Carrier protein having an adjuvant effect
#80Allergen from house-dust mites
#81Efficient protein expression system
#82Universal T-cell epitopes for anti-malarial vaccines
#83Multiple antigenic peptides immunogenic against
#84Diagnostic reagent for hepatitis C virus infection
#85Hepatitis-C virus type 4, 5 and 6
#86Human hematopoietic stem and progenitor antigen and methods for its use
#87Protein sequences containing antigenized antibodies for foot-and-mouth disease
#88Cyclosporine analogue mixtures and their use as immunomodulating agents
#89Deuterated cyclosporin analogs and their use as immunomodulating agents
#90HDV nucleic acid molecules and applications thereof
#91Amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
#92Contraceptives based on SP22 and SP22 antibodies
#93Expression library immunization
#94Hepatitis-C virus type 4, 5, and 6